
Mastocytosis: Unraveling the Genetic Threads of a Complex Disease
Mast cells build up in skin, bone marrow and other organs, causing skin lesions, bone pain and sometimes anaphylaxis; the KIT D816V mutation marks the systemic form.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Mast cells build up in skin, bone marrow and other organs, causing skin lesions, bone pain and sometimes anaphylaxis; the KIT D816V mutation marks the systemic form.

Arising in the cerebellum and mainly affecting children, medulloblastoma is profiled by tumor sequencing, with EP300 and CBP studied in the Group 3 subtype.

Inherited changes in CDKN2A are linked to multiple melanomas and nervous system tumors in MNSTS, a hereditary syndrome that often runs in families.

Variants in CDKN2A, BAP1 and MC1R can raise inherited melanoma risk, prompting closer skin examinations, sun protection and more informed treatment choices.

MCMS2 involves gene changes affecting cell growth and repair that leave skin less able to cope with UV damage; blood or saliva panels can detect them.

Explore the genetic insights into melorheostosis, a rare bone disorder. Learn how genetic testing aids in diagnosis and personalized treatment strategies.

Recurrent vertigo, fluctuating hearing loss and tinnitus define this inner ear disorder, where genetic markers, biomarkers and imaging may sharpen diagnosis.

Benign enchondromas and osteochondromas can distort bone growth in this rare inherited disorder, which stems from PTPN11 mutations that gene testing identifies.